HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.
![handle is hein.congrecreports/crptxadof0001 and id is 1 raw text is: AUTHENTICATED
U.S. GOVERNMENT
INFORMATION
GP
116TH CONGRESS [REPT. 116-584
2d Session HOUSE OF REPRESENTATIVES Part 1
ENSURING COMPLIANCE AGAINST DRUG DIVERSION ACT
OF 2019
NOVEMBER 16, 2020.-Committed to the Committee of the Whole House on the
State of the Union and ordered to be printed
Mr. PALLONE, from the Committee on Energy and Commerce,
submitted the following
R E P O R T
[To accompany H.R. 4812]
[Including cost estimate of the Congressional Budget Office]
The Committee on Energy and Commerce, to whom was referred
the bill (H.R. 4812) to amend the Controlled Substances Act to pro-
vide for the modification, transfer, and termination of a registra-
tion to manufacture, distribute, or dispense controlled substances
or list I chemicals, and for other purposes, having considered the
same, reports favorably thereon without amendment and rec-
ommends that the bill do pass.
CONTENTS
Page
I. Purpose and Sum m ary ............................................................................. 2
II. Background and Need for the Legislation .............................................. 2
III. Com m ittee H earings ................................................................................. 2
IV. Com m ittee Consideration ......................................................................... 3
V . Com m ittee V otes ....................................................................................... 3
VI. Oversight Findings .................................................................................... 3
VII. New Budget Authority, Entitlement Authority, and Tax Expenditures 4
VIII. Congressional Budget Office Estimate ...................................................... 4
IX. Federal M andates Statem ent ................................................................... 5
X. Statement of General Performance Goals and Objectives ....................... 5
XI. Duplication of Federal Programs ............................................................. 5
XII. Committee Cost Estimate ........................................................................... 5
XIII. Earmarks, Limited Tax Benefits, and Limited Tariff Benefits ............... 6
XIV. Advisory Committee Statement ............................................................... 6
XV. Applicability to Legislative Branch .......................................................... . 6
XVI. Section-by-Section Analysis of the Legislation ......................................... 6
XVII. Changes in Existing Law Made by the Bill, as Reported ...................... 6
19-006](ViewImageLocal?handle=hein.congrecreports/crptxadof0001&div=1&collection=&method=preview&ext=.png&size=3)